By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.


Four Essentials from CTFN this Week

The tribunal of Brazilian antitrust agency CADE is expected to clear the planned merger between 21st Century Fox and the Walt Disney Company between the end of January and early February with behavioral commitments, a source familiar with the case told CTFN.

The April 29-announced Sprint/T-Mobile merger remains under review at the staff level within the antitrust division of the U.S. Department of Justice, and staff is far from sending a recommendation to the next level, CTFN has learned.

C-Band Alliance – Intelsat
Sources polled by CTFN expressed cautious optimism that the Federal Communications Commission would approve the C-Band Alliance’s plan to sell mid-band spectrum by the second or third quarter of next year.

Energias de Portugal/China Three Gorges
State-owned enterprise China Three Gorges is committed to the €3.26 per share offer launched in May for Portuguese utility Energias de Portugal (EDP), and its separate €7.33 bid for Spanish subsidiary EDP Renováveis (EDPR), a source close to the bidder told CTFN.

Top stories on CTFN this week:  SFOXAEDP:PL.

©2018 CTFN. All rights reserved. No reprints, forwarding, sharing, or redistribution permitted. Use of this article is subject to the CTFN Terms of Service.

Bringing the marketplace leading coverage of major corporate developments, CTFN’s investigative reporters pursue news that matters to event-driven investors and deal professionals. Learn more at

For inquiries email or call +1 203 635 6555 or +44 (0)203 514 5314.

Stephen Velgot

Stephen Velgot

Stephen Velgot has more than twenty years experience as a research analyst. He most recently started an event driven research product at Renaissance Macro Research after covering risk arbitrage at ICAP and event driven situations at Susquehanna and Cathay Financial. Stephen has an MBA in Finance from New York University and a BS in Operations Research from Cornell University.


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.